More sites now recruiting for ZEN003694 NCT02705469 trial
|
4
|
Zenith Epigenetics
|
Jun 09, 2016 01:27PM
|
Re: Resverlogix Files 2017 Year-End Disclosure Documents and Announces Plans to Host a Symposium at the European Society of Cardiology Congress 2017
|
4
|
Resverlogix Corp.
|
Jul 25, 2017 11:10PM
|
Re: Last hour.....
|
4
|
Resverlogix Corp.
|
May 31, 2019 07:26PM
|
Re: China offering fast marketing approvals
|
4
|
Resverlogix Corp.
|
Aug 10, 2018 03:42PM
|
Re: Many hands make light work....
|
4
|
Resverlogix Corp.
|
Aug 22, 2018 07:25AM
|
Re-visiting Tundup's all-time top-rated message
|
4
|
Resverlogix Corp.
|
Jan 22, 2019 11:31AM
|
BiOasis BioTuesday article
|
4
|
BIOASIS TECHNOLOGIES INC
|
Aug 30, 2016 05:09PM
|
Re: Resverlogix Announces Publication on Apabetalone in Atherosclerosis Journal
|
4
|
Resverlogix Corp.
|
Nov 28, 2018 10:39AM
|
Re: Pointing in the right direction & bogus Lilly
|
4
|
Resverlogix Corp.
|
Dec 01, 2018 03:41PM
|
Re: Adjudication
|
4
|
Resverlogix Corp.
|
Dec 28, 2018 05:26PM
|
New content on Publications page of RVX website
|
4
|
Resverlogix Corp.
|
Jun 09, 2016 01:37PM
|
Re: AGM
|
4
|
Resverlogix Corp.
|
Aug 08, 2017 09:18PM
|
Re: Apabetalone MOA diagram
|
4
|
Resverlogix Corp.
|
Sep 28, 2019 06:26PM
|
BIO International & ISA 2018
|
4
|
Resverlogix Corp.
|
May 29, 2018 04:36PM
|
Re: Third Eye, AHA, US Listing
|
4
|
Resverlogix Corp.
|
Sep 08, 2019 01:06PM
|
Zenith to Present at AACR April 16-20 in New Orleans
|
4
|
Zenith Epigenetics
|
Mar 19, 2016 11:24AM
|
Re: MACE Events - Statistically Confusing
|
4
|
Resverlogix Corp.
|
Mar 01, 2019 12:37PM
|
Re: 2019 Potential Events
|
4
|
Resverlogix Corp.
|
Jul 18, 2019 04:12PM
|
Zacks SCR 8/5/19: Targeting September Readout for BETonMACE
|
4
|
Resverlogix Corp.
|
Aug 05, 2019 11:52AM
|
Re: One year after REDUCE-IT's 2018 AHA presentation
|
4
|
Resverlogix Corp.
|
Nov 11, 2019 09:23AM
|